General Information of the Compound
Compound ID
CP0256478
Compound Name
3-(2,4-dichlorophenyl)-2-propan-2-yl-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine
    Show/Hide
Structure
Formula
C16H19Cl2N3
Molecular Weight
324.255
Canonical SMILES
CC(C)n1nc2CCNCCc2c1-c1ccc(Cl)cc1Cl
    Show/Hide
InChI
InChI=1S/C16H19Cl2N3/c1-10(2)21-16(12-4-3-11(17)9-14(12)18)13-5-7-19-8-6-15(13)20-21/h3-4,9-10,19H,5-8H2,1-2H3
    Show/Hide
InChIKey
DIAIETRSPXZRRR-UHFFFAOYSA-N
Physicochemical Property
logP
4.126
Rotatable Bonds
2
Heavy Atom Count
21
Polar Areas
29.85
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 59752589
ChEMBL ID
CHEMBL4745055
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01746, 5-hydroxytryptamine receptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 400 nM
   TI
   LI
   LO
   TS